Podcasts are every 2 weeks now if time permits. Most OTC

New Post Public Reply Private Reply Replies (1) Message Board
adirondackhi
496
Podcasts are every 2 weeks now if time permits. Most OTC companies don't even offer one annually. Every 2 weeks is a thing of beauty.

Also I've noticed some complaints about management not providing anticipated or scheduled dates and quantities on everything. No longer offering this type of "help" is a new approach for them, and a very WISE one.

While more specific information may help to pacify nervous investors and especially nervous flippers, it helps one type of nervous flipper even more, and that's shorters. The only help that shorters of a hard working start up like this one should be getting is help to vacate the damn premises! LOL

Too much transparency does not help the pps at this stage of a companies growth, and short sellers are the main reason for that. Only impressive numbers in filings and press releases will shove them out of the way by ushering in a surge in buying pressure.

Management predicting ETA's for such filings and PR's will only help your pps to get hit harder as the shorters are handed the reassurance they need that such a surge in buying pressure is unlikely to materialize prior to managements predictions.

It's much better at this point, for TRUE investors anyhow, to wait for the actual completion of new deals, productions and/or shipments, to be officially announced to the public as completed in filings and/or press releases.

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading